Story perspectives

Health Secretary Proposes Easing Peptide Production Restrictions

4/17/2026

Center

Kennedy Advocates Peptide Reform

Health Secretary Robert F. Kennedy Jr. advocates easing restrictions on peptide production amid concerns about an illicit market for unregulated products.
He plans to appoint members to the Food and Drug Administration's (FDA) advisory panel to review seven peptides in July.
Critics warn that unapproved therapies could undermine safety standards.
Kennedy claims benefits from peptides, but skeptics doubt the FDA review process and the meeting could broaden access.

Left

Kennedy Proposes USPSTF Reform

Health Secretary Robert F. Kennedy Jr. announced plans to reform the USPSTF at a congressional hearing on April 16, 2026.
He described the panel as lackadaisical and negligent over the past two decades.
Kennedy aims to appoint new members to the USPSTF, which oversees essential medical screenings and procedures covered by insurance.
Delays persist, including the last three meetings postponed and the annual report not published.

1 of 2

Kennedy Advocates Peptide Reform

Health Secretary Robert F. Kennedy Jr. advocates easing restrictions on peptide production amid concerns about an illicit market for unregulated products.
He plans to appoint members to the Food and Drug Administration's (FDA) advisory panel to review seven peptides in July.
Critics warn that unapproved therapies could undermine safety standards.
Kennedy claims benefits from peptides, but skeptics doubt the FDA review process and the meeting could broaden access.

1 / 2